Dr. Izidore Lossos, MD
Claim this profileUniversity of Miami
Area of expertise
MALT Lymphoma
Izidore Lossos, MD has run 4 trials for MALT Lymphoma. Some of their research focus areas include:
Marginal Zone Lymphoma
Izidore Lossos, MD has run 3 trials for Marginal Zone Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
University Of Miami
Clinical Trials Izidore Lossos, MD is currently running
Loncastuximab Tesirine
for Marginal Zone Lymphoma
This trial is testing a medication called loncastuximab tesirine in patients with immune cell cancers. The medication works by finding and sticking to cancer cells, then releasing a poison to kill them. Researchers want to see if this treatment is effective and safe for these patients. Loncastuximab tesirine is a recently approved treatment for a type of immune cell cancer that has returned or not responded to previous treatments.
Recruiting
1 award
Phase 2
Mosunetuzumab
for Marginal Zone Lymphoma
The purpose of this study is to test a new medication called Mosunetuzumab to see if it can help people with Extranodal Marginal Zone Lymphoma (EMZL). This study will include people who have not yet received any treatment for cancer and whose cancer is in stage I-IV. This study will help doctors understand if Mosunetuzumab improves outcomes in people with EMZL and if it is safe to use.
Recruiting
1 award
Phase 2
5 criteria
More about Izidore Lossos, MD
Clinical Trial Related
16 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Izidore Lossos, MD has experience with
- Rituximab
- Combination Chemotherapy
- Loncastuximab Tesirine
- Mosunetuzumab
- Vitamin D
- Epcoritamab
Breakdown of trials Izidore Lossos, MD has run
MALT Lymphoma
Marginal Zone Lymphoma
Mantle Cell Lymphoma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Izidore Lossos, MD specialize in?
Izidore Lossos, MD focuses on MALT Lymphoma and Marginal Zone Lymphoma. In particular, much of their work with MALT Lymphoma has involved Stage II patients, or patients who are Stage I.
Is Izidore Lossos, MD currently recruiting for clinical trials?
Yes, Izidore Lossos, MD is currently recruiting for 3 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Izidore Lossos, MD has studied deeply?
Yes, Izidore Lossos, MD has studied treatments such as Rituximab, Combination Chemotherapy, Loncastuximab Tesirine.
What is the best way to schedule an appointment with Izidore Lossos, MD?
Apply for one of the trials that Izidore Lossos, MD is conducting.
What is the office address of Izidore Lossos, MD?
The office of Izidore Lossos, MD is located at: University of Miami, Miami, Florida 33136 United States. This is the address for their practice at the University of Miami.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.